Free β-hCG MoM | PAPP-A MoM | Biochemical risk (1 in) | Combined risk (1 in) | ||
---|---|---|---|---|---|
Within-day variations of calculated risk | High risk * | ||||
Mean ± SD | 1.87 ± 0.08 | 0,29 ± 0,01 | 52.6 ± 6.2 | 154.4 ± 16.1 | |
CV† (%) | 4.27 | 3.45 | 11.72 | 10.45 | |
Medium risk ** | |||||
Mean ± SD | 0.59 ± 0,03 | 0,29 ± 0,01 | 732.6 ± 76.0 | 699.9 ± 77.2 | |
CV† (%) | 5.08 | 3.45 | 10.37 | 11.03 | |
Low risk *** | |||||
Mean ± SD | 1.87 ± 0.08 | 1.26 ± 0.05 | 3060.8 ± 323.5 | 2527.7 ± 328.3 | |
CV† (%) | 4.27 | 3.97 | 10.57 | 12.98 | |
Human serum | |||||
Mean ± SD | 1.47 ± 0.07 | 1.79 ± 0.06 | 8668.2 ± 819.4 | 7313.9 ± 900.9 | |
CV† (%) | 4.76 | 3.35 | 9.45 | 12.32 | |
Between-day variations of calculated risk | High risk * | ||||
Mean ± SD | 1.70 ± 0.09 | 0.27 ± 0.01 | 45.39 ± 5.5 | 145.6 ± 18.2 | |
CV† (%) | 5.26 | 3.43 | 12.12 | 12.50 | |
Medium ris k ** | |||||
Mean ± SD | 0.59 ± 0.03 | 0.27 ± 0.01 | 661.4 ± 68.7 | 646.1 ± 68.58 | |
CV† (%) | 4.3 | 3.43 | 10.39 | 11.54 | |
Low risk *** | |||||
Mean ± SD | 1.70 ± 0.09 | 1.26 ± 0.05 | 2442.6 ± 304.6 | 1993.3 ± 219.7 | |
CV† (%) | 5.26 | 4.28 | 12.47 | 11.02 | |
Human serum | |||||
Mean ± SD | 1.36 ± 0.08 | 1.76 ± 0.09 | 7446.5 ± 796.8 | 6146.4 ± 785.4 | |
CV† (%) | 6.17 | 5.20 | 10.70 | 12.77 |